Scientists test best way to swallow diabetes pill
NCT ID NCT05996874
Summary
This study tested a new tablet version of the diabetes medicine semaglutide (Rybelsus®) in 121 healthy men. The goal was to see how the amount of water taken with the pill and the timing of breakfast afterward affect how much medicine gets into the bloodstream. Participants took the tablet daily for 10 days under different conditions to gather this information.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Profil Institut für Stoffwechselforschung GmbH
Neuss, 41460, Germany
Conditions
Explore the condition pages connected to this study.